CARDIFF ONCOLOGY, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.07 USD | +2.01% |
|
-6.44% | +175.00% |
Chart calendar Cardiff Oncology, Inc.
cfdec042a2adba155d668edba05c8f.nXTOu9QvV4M7JpeKwaVnGxhPIbNBi3NIGN-7w8yG6GI.sEGL3Y5AZ8ZyEM3dtYgNWVklbtEW5l4KYpHO9Z6xqVTNDILPhl1m9mh19A~89e062094bfbd4c1a65e03b17e3ee77d
Upcoming events on Cardiff Oncology, Inc.
Past events on Cardiff Oncology, Inc.
| 2024-04-09 04:30 pm | American Association for Cancer Research Meeting - Abstract Number #CT275 |
| 2024-04-08 12:00 pm | American Association for Cancer Research Meeting - Abstract Number #1934 |
| 2024-04-08 12:00 pm | American Association for Cancer Research Meeting - Abstract Number #2031 |
| 2024-04-07 04:30 pm | American Association for Cancer Research Meeting - Abstract Number #606 |
| 2024-04-07 04:30 pm | American Association for Cancer Research Meeting - Abstract Number #945 |
| 2024-03-04 01:30 pm | TD Cowen Health Care Conference |
| 2024-02-29 04:30 pm | Q4 2023 Earnings Call |
| 2024-02-29 04:05 pm | Q4 2023 Earnings Release |
| 2023-11-29 10:00 am | Piper Sandler Healthcare Conference |
| 2023-11-02 04:30 pm | Q3 2023 Earnings Call |
| 2023-11-02 04:05 pm | Q3 2023 Earnings Release |
| 2023-09-26 05:00 pm | Business Update Call |
| 2023-09-13 11:30 am | H.C. Wainwright Global Investment Conference |
| 2023-09-12 09:05 am | Baird Global Healthcare Conference |
| 2023-08-09 04:05 pm | Q2 2023 Earnings Release |
| 2023-08-07 05:00 pm | Business Update Call |
| 2023-06-15 12:00 pm | Annual General Meeting |
| 2023-06-08 10:30 am | Jefferies Global Healthcare Conference |
| 2023-05-04 04:10 pm | Q1 2023 Earnings Release |
| 2023-03-07 12:50 pm | Cowen Health Care Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,25 0,38 -35.27% | 0,37 0,27 36.82% | 0,36 0,25 42.74% | 0,39 0,27 40.47% | 0,49 0,28 75.22% | 0,24 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -16,7 -16,7 0.42% | -19,1 -17,2 -10.92% | -28,9 -26,6 -8.55% | -39,9 -41,6 3.98% | -45,4 -48,3 5.92% | -47,3 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -16,4 -16,5 0.71% | -19,3 -18,1 -6.53% | -28,3 -25,9 -9.42% | -38,7 -41,0 5.7% | -41,4 -45,0 7.88% | -46,3 |
|
Net income Million USD | Released Forecast Spread | -16,7 -16,5 -1.06% | -22,6 -20,6 -9.76% | -28,3 -25,9 -9.44% | -38,7 -40,9 5.22% | -41,5 -45,0 7.85% | -46,3 |
|
EPS USD | Released Forecast Spread | -2,80 -3,09 9.39% | -1,08 -1,09 1.14% | -0,73 -0,66 -10.05% | -0,89 -0,94 5.12% | -0,93 -1,01 7.92% | -0,98 |
| Announcement Date | 27/02/20 | 25/02/21 | 24/02/22 | 02/03/23 | 29/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,13 0,03 289.23% | 0,07 0,05 56.88% | 0,09 0,07 32.85% | 0,09 0,07 36.36% | 0,13 0,07 86.59% | 0,08 0,06 49.28% | 0,11 0,06 94.24% | 0,14 0,04 276% | 0,16 0,04 316% | 0,06 | 0,06 | 0,06 | 0,07 | 0,03 |
|
EBIT Million USD | Released Forecast Spread | -9,53 -7,15 -33.32% | -11,1 -9,71 -14.05% | -10,4 -11,5 9.02% | -8,99 -11,5 22.01% | -9,39 -10,7 11.88% | -12,1 -10,6 -14.13% | -12,2 -12,1 -0.67% | -10,8 -13,2 17.74% | -10,3 -12,7 18.67% | -11,4 | -11,5 | -12,1 | -12,3 | -13,5 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -9,44 -6,97 -35.39% | -11,0 -9,65 -13.91% | -10,4 -11,4 8.54% | -8,57 -11,5 25.35% | -8,70 -10,5 17.05% | -11,2 -10,3 -9.27% | -11,2 -11,7 5% | -9,73 -12,9 24.37% | -9,34 -12,4 24.73% | -11,1 | -11,3 | -11,9 | -12,0 | -13,4 |
|
Net income Million USD | Released Forecast Spread | -9,45 -6,98 -35.42% | -11,0 -9,65 -13.94% | -10,4 -11,4 8.51% | -8,58 -11,5 25.32% | -8,72 -10,5 16.85% | -11,2 -10,3 -9.29% | -11,2 -11,7 4.98% | -9,74 -13,2 26% | -9,34 -12,4 24.7% | -11,1 | -11,3 | -11,9 | -12,0 | -13,4 |
|
EPS USD | Released Forecast Spread | -0,25 -0,17 -45.63% | -0,25 -0,23 -7.91% | -0,24 -0,25 4.76% | -0,20 -0,26 24.24% | -0,20 -0,24 15.97% | -0,25 -0,23 -10.62% | -0,25 -0,26 3.85% | -0,22 -0,29 24.14% | -0,21 -0,28 24.32% | -0,25 | -0,25 | -0,24 | -0,24 | -0,29 |
| Announcement Date | 24/02/22 | 05/05/22 | 04/08/22 | 03/11/22 | 02/03/23 | 04/05/23 | 09/08/23 | 02/11/23 | 29/02/24 | - | - | - | - | - |
More events
Past sector events for Cardiff Oncology, Inc.
| Today | GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release |
| Today | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-26 01:00 am | BB BIOTECH AG: Q1 2024 Earnings Release |
| 2024-04-25 | BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-25 | PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release |
| 2024-04-25 | HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-25 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-25 | CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-25 07:00 am | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release |
| 2024-04-25 02:00 am | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CRDF Stock
- Calendar Cardiff Oncology, Inc.
